NextCure, Inc. - NXTC

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Mar 05, 2026 SCHEDULE 13D/A 1.0% View
Feb 17, 2026 SCHEDULE 13G Ikarian Capital, LLC 9.99% 363,035 View
Feb 17, 2026 SCHEDULE 13G Neil Shahrestani 9.99% 363,035 View
Feb 17, 2026 SCHEDULE 13G/A Squadron Master Fund LP 9.9% 271,127 View
Feb 17, 2026 SCHEDULE 13G/A Squadron Capital Management LLC 9.9% 271,127 View
Feb 17, 2026 SCHEDULE 13G/A Matthew Sesterhenn 9.9% 271,127 View
Feb 17, 2026 SCHEDULE 13G/A William Blank 9.9% 271,127 View
Feb 12, 2026 SCHEDULE 13G SilverArc Capital Management, LLC 5.02% 176,057 View
Feb 12, 2026 SCHEDULE 13G Devesh Gandhi 5.02% 176,057 View
Jan 29, 2026 SCHEDULE 13G/A Affinity Asset Advisors, LLC 9.99% 348,607 View
Jan 29, 2026 SCHEDULE 13G/A Michael Cho 9.99% 348,607 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.